Work

How Unavoidable Are Analytical Treatment Interruptions in HIV Cure–Related Studies?

Year: 2019

Type: article

Abstract: In this discussion, 2 established researchers and clinical trialists debate their opposing views on the utility, benefits, and risks of the use of analytical interruption of antiretroviral therapy as a clinical trial end point and outcome measure in human studies seeking to induce remission of or eradicate human immunodeficiency virus infection.

Source: The Journal of Infectious Diseases

DOI: 10.1093/infdis/jiz222

Authors: David M Margolis, Steven G Deeks

Institutions: University of North Carolina at Chapel Hill, University of California, San Francisco

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases